Federal contract award

15B20526P00000060

NATIONAL DRUG CODE: 66215-0608-06 TRADE NAME: UPTRAVI 800MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE FEB

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Justice
OfficeFMC DEVENS
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract value$23.4K
Potential contract value / ceiling$23.4K
Start dateFeb 8, 2026
Current end dateFeb 8, 2026
Potential end dateFeb 8, 2026
Latest award activityFeb 8, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Feb 8, 20260$0NATIONAL DRUG CODE: 66215-0608-06 TRADE NAME: UPTRAVI 800MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE FEB
Feb 8, 2026P00001$0NATIONAL DRUG CODE: 66215-0608-06 TRADE NAME: UPTRAVI 800MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE FEB

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.